Navigation Links
Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
Date:3/6/2013

stem conditions, including agitation, acute repetitive seizures and insomnia.  Alexza's products are based on the Staccato® system, a hand-held inhaler that is designed to deliver a drug aerosol to the deep lung, providing rapid systemic delivery and therapeutic onset with ease and convenience for patients. 

ADASUVE® (Staccato loxapine) is Alexza's first approved product, which was approved by the U.S. Food and Drug Administration in December 2012 and by the European Medicines Agency in February 2013.  Grupo Ferrer Internacional , S.A. is Alexza's commercial partner for ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.  The commercial launch of ADASUVE is planned for the third quarter 2013 in the U.S. and Europe.

For more information about Alexza, the Staccato system technology or the Company's development programs, please visit www.alexza.com.  For more information about ADASUVE, please visit www.adasuve.com

ADASUVE® and Staccato® are registered trademarks of Alexza Pharmaceuticals, Inc.

Safe Harbor Statement
The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the ability for Alexza and Ferrer to effectively and profitably commerciali
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuve™ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
6. Alexza Announces Management Promotions
7. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
8. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
11. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  ConvaTec, a privately-held medical ... Clerkin has been appointed chief financial officer of ... Clerkin was previously executive vice president and chief financial ... -based biotechnology company.  Mr. Clerkin was part of a ... Elan, culminating in its sale to Perrigo, a pharmaceutical ...
(Date:7/22/2014)... 2014 The steady decline of pharmaceutical ... previously rep-friendly specialties, according to the spring 2014 ... firm ZS Associates.      AccessMonitor™ aggregates ... sales teams. The report examines how often approximately ... pharmaceutical sales reps who visit their offices. ...
(Date:7/22/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... outsourcing company with operations in China ... that it will release financial results for the second quarter ... Wednesday, August 13, 2014 (which will be Thursday morning, August ... on the investor relations section of the Company,s website at ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
... 10, 2011 USANA Health Sciences, Inc. (NYSE: ... nutritional gaps are common in the average American diet and ... those gaps.  However, USANA scientists and advising physicians caution that ... Dietary Guidelines for Americans, 2010 and ...
... MATEO, Calif., Feb. 10, 2011 AlphaDetail, a leader ... biotech industries, reported a 30% increase in revenue in ... time in the company,s history. "Our clients ... provides the marketing research solutions that get at the ...
Cached Medicine Technology:USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2AlphaDetail Revenue Soars 30% in 2010 2
(Date:7/22/2014)... July 22, 2014 Alan Tonelson of ... young child. While most kids outgrow the inhibiting speech ... He is among the three million people in the ... mild to severe. Throughout his youth, he participated in ... sessions and visits with private speech-and-language pathologists. None helped ...
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person Should Know ... young people can read. , But be careful! What’s in this ... people have been living with all their lives. And If the ... sex to death, this self-help book deals directly with social reality ... it like it is. , Tune in to “The Big Secrets” ...
(Date:7/22/2014)... 2014 One woman who looked at diet ... 20 pounds. Unfortunately, the weight loss came at a price ... of her time using the pill, and says her personality ... and insomnia as a result of the caffeine content of ... the age of 37 because of a diet pill she ...
(Date:7/22/2014)... Industry-leading health business information publisher Atlantic Information Services ... Pharmacy Trends and Strategies: 2014 , the latest edition ... of the current state of the specialty pharmacy industry. ... , Specialty drugs on the exchanges ... details of coinsurance levels by plan, by metal tier ...
(Date:7/22/2014)... Cumberland Pediatric Dentistry and Orthodontics stresses ... anxiety-free dental care for children, while maintaining the most ... care. , The orthodontic team is committed to ... adults and those with special needs. Whether a child ... unique care, such as cleft palate, Cumberland Pediatric Dentistry ...
Breaking Medicine News(10 mins):Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 3
... new study published in the journal, Molecular Psychiatry suggested that ... susceptible to sleepwalking. Sleepwalking is a complex disorder and affects ... cent of adults. Though the condition is harmless, it may ... to others. Scientists examined a family of genes known as ...
... called C150T transition in people over 100 years old, a ... mutation was found in the mitochondrial DNA of white blood ... centenarians. The researchers found that 17 per cent of the ... 3.4 per cent of 117 control subjects under the age// ...
... all newly-diagnosed lung cancer cases. Smoking inflicts serious damage to ... quit, as it takes time for the tissue to recover. ... in the form of loss of a gene that could ... Texas have now shown that a close chemical relative of ...
... of the National Academy of Science, recently published a study ... that a brain protein called WAVE-1 may play a key ... found throughout the brain and plays an important role in ... that were produced, without the WAVE-1// protein, by the researchers ...
... by Juliette van den Dolder at the University of Nijmegen ... bone fractures with the help of specially prepared titanium mesh ... into a bone fracture in a rat. They allowed bone ... bone growth being stimulated by the bone// marrow cells. They ...
... it is no term to be happy about, because this ... could affect those individuals whose work or lifestyle demands them ... for a long time without a break could cause blood ... the lungs with possible fatal consequences. This condition is identical ...
Cached Medicine News:Health News:Bones repair themselves with bone marrow cells 2
... Mumps IgG Enzyme- linked Immunosorbent Assay (ELISA) ... determination of IgG antibody to Mumps virus ... be used for the determination of immune ... be used to demonstrate seroconversion or a ...
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... Ultra Laboratory has been uniquely designed ... single facility to integrated networks spanning ... to management reporting and accounts receivable, ... precise laboratory management. All system modules ...
Medicine Products: